Olga Davydova v. HHS - Tdap, Guillain-Barré syndrome (GBS) (2021)

Olga Davydova filed a petition for compensation under the National Vaccine Injury Compensation Program on February 8, 2019, alleging injury from a Tdap vaccine received on April 25, 2018. The Tdap vaccine is listed on the Vaccine Injury Table.

Ms. Davydova claimed she developed Guillain-Barré syndrome (GBS) as a result of the vaccination and suffered residual effects for more than six months.

The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused Ms. Davydova's GBS or any other injury.

Despite maintaining their respective positions, the parties reached a stipulation to settle the case. The stipulation provided for an award of $60,000.00 to Ms.

Davydova as compensation for all damages. The Special Master adopted the stipulation and awarded the compensation.

The decision was filed on January 26, 2021. The public decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or expert witnesses.

Petitioner counsel was Anne C. Toale, and respondent counsel was Claudia B.

Gangi. Special Master Thomas L.

Gowen issued the decision.